Pharmacological treatments for acute migraine: quantitative systematic review
about
sameAs
Zolmitriptan for acute migraine attacks in adultsGabapentin for chronic neuropathic pain and fibromyalgia in adultsAspirin with or without an antiemetic for acute migraine headaches in adultsParacetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adultsIbuprofen with or without an antiemetic for acute migraine headaches in adultsSumatriptan (intranasal route of administration) for acute migraine attacks in adultsSumatriptan (subcutaneous route of administration) for acute migraine attacks in adultsSumatriptan (oral route of administration) for acute migraine attacks in adultsIbuprofen with or without an antiemetic for acute migraine headaches in adultsGabapentin for chronic neuropathic pain and fibromyalgia in adultsAspirin with or without an antiemetic for acute migraine headaches in adultsParacetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adultsDiagnosis and management of the primary headache disorders in the emergency department settingIndirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunctionA review of the pharmacoeconomics of eletriptan for the acute treatment of migrainePlacebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacksEfficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptomsPatient satisfaction with eletriptan in the acute treatment of migraine in primary carePlacebo and other psychological interactions in headache treatment.Oral metoclopramide as an adjunct to analgesics for the outpatient treatment of acute migraine.Real-Time Assessment of the Effect of Biofeedback Therapy with Migraine: A Pilot Study.Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache.Do placebo response rates from cessation trials inform on strength of addictions?Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.Eletriptan in migraine.Methodological issues in systematic reviews of headache trials: adapting historical diagnostic classifications and outcome measures to present-day standards.Safety and efficacy of eletriptan in the treatment of acute migraine.A review of evidence-based medicine and meta-analytic reviews in migraine.Eletriptan: a review and new perspectives.Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scoresMeta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.Optimizing prophylactic treatment of migraine: Subtypes and patient matching.Economic evaluation of pharmacotherapy of migraine pain: a review of the literature.Sponsorship-related outcome selection bias in published economic studies of triptans: systematic review.The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg.Economic and patient-reported outcomes of oral triptans in the treatment of migraine.A new stability indicating HPLC method for related substances in zolmitriptan.Sublingual Delivery of Frovatriptan: An Indication of Potential Alternative Route.An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
P2860
Q24194592-28ECFBDF-E6F6-41D7-890E-918B78C71BF7Q24194998-3A4972D6-39EA-435A-9127-9F9AD85A09B1Q24197721-5A4BACEA-2FE0-44AF-A02A-CE39096E018CQ24197826-19B69050-1697-4B0F-97AA-AEA6E92B90E3Q24197974-D21A3665-6AEC-46F0-817C-D4B8D02C4A96Q24203640-138E1B34-10C5-40FD-9BD6-D1B6540DF065Q24203684-73C39B17-3E47-47EA-8FDA-6EEBCE3A2D67Q24203707-DF5E9475-E214-4F38-9BF5-91120580A7ABQ24234446-6A86A6CA-A321-43B5-9456-2D5E2AE73002Q24235709-BBFD4A57-C880-475A-88F8-E5361354CFE9Q24235987-2A3D66E8-E299-46F3-A875-9A2E682614D1Q24236410-A81E1D52-A94A-4711-8E32-19E3EC6E236AQ24651176-937438FC-F617-488B-8BF5-FCB79A4380A5Q25256846-1427DD76-A00E-47E6-A9C7-8D647EB2EAB1Q26823673-5F6D9EE9-5B30-40DE-BAB4-7DA560E40D45Q28171147-37FF79B4-649F-4622-BB34-DA997652611BQ28199015-C2644A85-D0CA-4EB4-890B-EF43BEAAAA0AQ28221721-C0C56C89-2052-48E8-9CA0-CAD062A35B59Q34257107-A8A57E95-4A87-42D7-9B2C-0513C5087162Q34588506-9D83B601-85F0-4BC1-A484-44E23530A5B4Q34667894-3630DD0F-5D9F-4EAD-85C5-FD5D48B96BCCQ34691359-EB0837D8-D995-45E3-93B8-6AEF0AC8920DQ35684215-BE53464E-C75B-41C1-B211-1D0A48D5EB77Q35859923-25A1E1CA-071B-4183-A42D-8D45533C217BQ36013751-4E0D6EF5-431B-466B-B206-C922BA249A49Q36106757-46AFCB86-498D-4FD4-B617-DA93119D69CFQ36161561-DD9201EB-A72D-4237-A453-593818F099ADQ36408742-D4A4FA41-CA8D-435E-A32A-4FBA96B370BDQ36632277-DFFFB50C-F468-43C2-88C2-C44568790611Q36641480-7742D07B-4A30-456C-9BCC-B9B20F7FC9B2Q36757015-E320E5F9-36C5-4D7F-A6A8-0193B6F4ED4FQ36947155-F25865A7-891E-4F21-8248-B6F64476C9E7Q37052803-81EEDFF7-98B0-4E73-8564-9B9FE407DD19Q37641349-DF2BD4D6-3342-455F-A156-FB4AF9E2B4AAQ37864874-E2976301-D82F-4092-BA76-199D1EECD2AEQ39384899-408DC454-60A0-48E1-81F6-6BE7D4B064A3Q40385073-912EDD22-7817-414E-AC4A-F7C9D1A4FEFDQ40965235-7AFBCE2C-AA30-49BE-9FA6-851D8ACF7B04Q42738044-85084B6A-190D-4BA2-A6DD-548B847A4420Q44175949-C0A2DBD3-0697-42A3-AE53-D0F4A52134A4
P2860
Pharmacological treatments for acute migraine: quantitative systematic review
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacological treatments for acute migraine: quantitative systematic review
@ast
Pharmacological treatments for acute migraine: quantitative systematic review
@en
Pharmacological treatments for acute migraine: quantitative systematic review
@nl
type
label
Pharmacological treatments for acute migraine: quantitative systematic review
@ast
Pharmacological treatments for acute migraine: quantitative systematic review
@en
Pharmacological treatments for acute migraine: quantitative systematic review
@nl
prefLabel
Pharmacological treatments for acute migraine: quantitative systematic review
@ast
Pharmacological treatments for acute migraine: quantitative systematic review
@en
Pharmacological treatments for acute migraine: quantitative systematic review
@nl
P1433
P1476
Pharmacological treatments for acute migraine: quantitative systematic review
@en
P2093
Anna D Oldman
Lesley A Smith
P304
P356
10.1016/S0304-3959(02)00024-6
P407
P577
2002-06-01T00:00:00Z